The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively...
A quick rundown of the highlights so far, and what’s still left to look forward to.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we...
We unpack the science behind the ECS and its significance in a range of chronic conditions.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is...
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
